Sustained hair regrowth with continued ritlecitinib treatment through week 48 in patients with alopecia areata with or without early target responses: Post hoc analysis of the ALLEGRO phase 2b/3 trial
{{output}}
Background: Few treatments for alopecia areata have demonstrated sustained efficacy. Objective: Evaluate the efficacy and safety of continued r... ...
